Uterine disorders are common postpartum diseases in dairy cows. In practice, uterine treatment is often based on systemic or locally applied antimicrobials with no previous identification of pathogens. Accurate on-farm diagnostics are not available, and routine testing is time-consuming and cost intensive. An accurate method that could simplify the identification of uterine pathogenic bacteria and improve pathogen-specific treatments could be an important advance to practitioners. The objective of the present study was to evaluate whether a database built with uterine bacteria from European dairy cows could be used to identify bacteria from Argentinean cows by Fourier transformed infrared (FTIR) spectroscopy. Uterine samples from 64 multiparous dairy cows with different types of vaginal discharge (VD) were collected between 5 and 60 days postpartum, analyzed by routine bacteriological testing methods and then re-evaluated by FTIR spectroscopy (n = 27). FTIR spectroscopy identified Escherichia coli in 12 out of 14 samples and Trueperella pyogenes in 8 out of 10 samples. The agreement between the two methods was good with a Kappa coefficient of 0.73. In addition, the likelihood for bacterial growth of common uterine pathogens such as E. coli and T. pyogenes tended to increase with VD score. The odds for a positive result to E. coli or T. pyogenes was 1.88 times higher in cows with fetid VD than in herdmates with clear normal VD. We conclude that the presence of E. coli and T. pyogenes in uterine samples from Argentinean dairy cows can be detected with FTIR with the use of a database built with uterine bacteria from European dairy cows. Future studies are needed to determine if FTIR can be used as an alternative to routine bacteriological testing methods.

The main aim of this study was to assess the associations between the timing of lameness clinical case occurrence in lactation with productive and reproductive performances in grazing Holstein cows. A cohort study was carried out on a dataset with records from a commercial dairy herd (Buenos Aires, Argentina) for cows that calved and were dried off from January 2010 through June 2017. The first recorded event of lameness per lactation was considered for the study. Criteria for lactation inclusion included not having uterine diseases, mastitis, or anovulatory cysts during the studied risk period (i.e., up to 200 DIM). Therefore, a total of 7156 out of 20,086 lactations were included in the statistical analysis. The association between lameness case occurrence in lactation (cows not lame (LG0) vs. lame cows between parturition and first service (LG1) vs. lame cows between first service and first pregnancy (LG2)) with productive (i.e., accumulated milk yield to 150 DIM (MILK150) and 300 DIM (MILK305)) and reproductive performances (hazard of insemination and pregnancy) was analyzed with linear regression models and proportional hazard regression models, respectively. Lame cows produced 161 and 183 kg less MILK150 and MILK305 than non-lame herd mates, respectively. Moreover, LG1 cows produced 216 kg less MILK150 and 200 kg less MILK305 than LG0 cows, and LG2 cows also produced 58 kg less MILK150 and 158 kg less MILK305 than LG0 cows. The LG1 cows had a lower hazard of service than LG0 cows (HR = 0.43, 95%CI = 0.39–0.47). Furthermore, LG1 cows had a lower hazard of pregnancy than LG0 cows (HR = 0.52, 95%CI = 0.46–0.59) and took longer to get pregnant than LG0 cows (median [95%CI], 139 [132–144] vs. 101 [99–103]). Moreover, LG2 cows had a much lower hazard of pregnancy than LG0 cows (HR = 0.08, 95%CI = 0.05–0.12) and much longer calving to first pregnancy interval than LG0 cows (188 [183–196] vs. 101 [99–103]). In conclusion, cows that become lame in early lactation produce less milk and have lower hazards of insemination and pregnancy than herd mates that are healthy or become lame later in lactation. In addition, cows that become lame immediately after the voluntarily waiting period have the poorest reproductive performance (i.e., they have the lowest hazard of pregnancy and the longest calving to pregnancy interval).

Objective To assess the efficacy of antibiotic usage for the treatment of puerperal metritis (PM) and its association with reproductive performance, a retrospective cohort study including a total of 9168 records of cows from a dairy farm in Argentina was run. Material and methods Cows having a PM3 (metricheck, scale 0–3) and treated with ceftiofur (ceftiofur crystalline free acid, 6.6 mg/kg) at 0–21 days postpartum (p. p.) (n = 2688), and cows having a PM 1–2 and not treated with an antibiotic at 0–21 days p. p. (n = 6480) were included in the study. All cows were reexamined with metricheck to assess the clinical cure (vaginal discharge [VD] score 0), partial cure (VD score similar or lower than previous), no cure (VD score higher than previous). Cows with a metricheck VD1–3 after 0–21 days p. p. were diagnosed as clinical endometritis (CE) 1–3. The occurrence of PM1–3, cure rate, calving to conception interval, the hazard of pregnancy, odds for non-pregnancy, and odds for CE were analyzed using SAS software. Results A total of 8876 PM1–3 records were included, 2435 records of PM3 treatments with ceftiofur (27.43 %), and 6441 records of PM1–2 (72.57 %) with no treatment. Cows having PM1 and PM2 became pregnant 14 and 12 days earlier than cows with PM3 (p < 0.001). The PM3 ceftiofur treated cows had a clinical cure of 24.85 % (PM0); 53.63 % had a partially cure; and 18.52 % no cure. Conversely, cows with PM1–2 had a 51.96 %, 20.70 %, and 24.53 % cure rate, respectively (p < 0.001). Cows having complete cure became pregnant 13 and 11 days earlier than cows having partial cure and no cure (p < 0.001). Cows that had PM3 during the first 21 days p. p. had twice the chances of developing CE compared to cows having PM1–2 (41.28 % vs. 24.14 %, p < 0.001). After 21 days p. p., less than 1 % of cows with clinical cure developed CE compared to 63.32 % that developed CE with partial cure, and 38.21 % with no cure (p < 0.001). Conclusion and clinical relevance After ceftiofur treatment, 78 % of cows were cured when measured by disappearance of fetid VD but only 25 % of cows had clinical cure when measured by appearance of a clear VD. The cows that remained with clinical metritis had more chances of having CE after 21 days p. p. and had more days open than cows with clear normal VD.

This study aimed to evaluate the association between colostrum quality, as indicative of the immune status of the cows, and peripartum disease risk occurrence in a herd of grazing dairy cows. A prospective cohort study was conducted on a grazing dairy farm with 3000 Holstein milking cows from 15 March 2022 to 15 March 2023. Multivariable binary logistic models evaluated the association between colostrum quality (expressed in Brix grades as a continuous predictor) and the risk of peripartum diseases (including dystocia, stillbirth, retention of fetal membranes, metritis, and clinical endometritis). We found that colostrum quality was negatively associated with the risk of dystocia (p = 0.02), stillbirth (p < 0.01), clinical endometritis (p = 0.02), and total peripartum diseases (p < 0.01). Conversely, colostrum quality was not related to the risk of retention of the placenta (p = 0.25) or metritis (p = 0.76). Additionally, we found that the calving season affected colostrum quality (p < 0.01). Conversely, parity number, dry period length, and milk yield in previous lactation did not affect it (p > 0.10). We concluded that colostrum quality, expressed in Brix grades, is negatively associated with peripartum disease risk in dairy cows and could be a useful indicator of the immune status of the cow.

To address the rising threat of antimicrobial resistance, many countries are making efforts to establish baseline data and monitor antimicrobial use (AMU) in livestock. Although international reporting uses the total mass of antimicrobial agents standardized by animal biomass, other metrics may be more useful for individual countries, farmers or veterinarians to monitor progress over time. Using garbage can audits, we collected observational data on on-farm AMU from a convenience sample of 29 Argentinian dairy farms, separated into adult and youngstock groups, and calculated mass- and course-based metrics to benchmark estimated usage over the first 365 d of collection. Aggregated data from all farms gave an overall average (mean) usage of 25.8 mg/PCU; when calculated per farm, median AMU was 19.37 mg/PCU (range 4.97 to 58.90 mg/PCU). The third-generation cephalosporin, ceftiofur, was widely used as an injectable in adult cattle, while enrofloxacin was commonly used in youngstock. Oral ciprofloxacin - marketed as part of a multivitamin preparation for use in newborn calves - while only found on 4 farms, constituted 34% of all Category B antimicrobials, recommended as restricted for use in livestock by the European Medicines Agency. Course-based metrics demonstrated that high medicine usage on individual farms tended to occur in only one of the following categories: Category B medicines, youngstock, intramammary or systemic treatment in adults. These granular metrics help identify problem areas for individual farms, but may be less useful for formulating policy and measuring progress. A reduction in Category B usage appears to be a good opportunity for improved stewardship for the majority of participants and potentially for similar intensifying farms in the Argentinian dairy sector, although country-specific data (such as actual course doses and lengths used in the country) would improve calculation methodology for national monitoring.